A study of evaluating issue of the drug development scientifically and predicting the adaptive development quantitatively.

点击翻译按钮获取中文摘要

Information about a drug development is available at two sources, one is from the National Institution of Public Health and the other is the international clinical trial research platform managed by WHO. Finally all information of the clinical study is collected to the site managed by WHO. Almost all the information of Hepatitis type C was available from the portal site managed by WHO, whileonly a half of the information was available from the portal site of the domestic institution. We showed that the information of the drug development can be obtained more than two years earlier rather than waiting the publication of the study, using these sites.